Last updated: February 25, 2024
Sponsor: Phramongkutklao College of Medicine and Hospital
Overall Status: Active - Recruiting
Phase
4
Condition
Muscle Pain
Arthritis And Arthritic Pain
Osteoarthritis
Treatment
Normal Saline
Sodium Hyaluronate
Triamcinolone Acetonide 10mg/mL
Clinical Study ID
NCT06279507
PMK-00007
Ages > 50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All participants who had been diagnosed as knee osteoarthritis according to ACRcriteria with symptom of knee pain
- Pain visual analog scare of 4 or higher
Exclusion
Exclusion Criteria: Participants who have
- Cognitive impairment
- History of aller to Hyaluronic acid or its component
- History of knee arthropathy
- Concomitant with inflammatory arthritis
- Serious comorbidities or bedridden status
- Current pregnancy or lactation
- Currently use of symptomatic slow acting drugs for osteoarthritis (SYSADOA)
- Communication problem
Study Design
Total Participants: 176
Treatment Group(s): 3
Primary Treatment: Normal Saline
Phase: 4
Study Start date:
February 10, 2024
Estimated Completion Date:
June 30, 2025
Study Description
Connect with a study center
Phramongkutklao Hospital
Bangkok, 10400
ThailandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.